What is the recommended protocol for using Plasmalyte in the management of diabetic ketoacidosis?

Plasmalyte in DKA Management

Plasmalyte (or other balanced crystalloids) should be used as the primary resuscitation fluid in diabetic ketoacidosis, as it leads to faster resolution of metabolic acidosis compared to 0.9% normal saline, without increasing ketosis or adverse outcomes.

Rationale for Balanced Crystalloids Over Normal Saline

The traditional approach using 0.9% normal saline can worsen hyperchloremic metabolic acidosis due to its supraphysiological chloride content (154 mEq/L), which complicates the assessment of DKA resolution. Plasmalyte-148 has an electrolyte composition closer to human plasma and does not cause hyperchloremic acidosis 1, 2.

Key Clinical Outcomes

Time to DKA Resolution:

• Plasmalyte achieves significantly faster resolution at 24 hours: 69% vs. 36% with saline (p = 0.002) 1
• In adults, median time to DKA resolution was 13.0 hours with balanced crystalloids vs. 16.9 hours with saline (adjusted HR 1.68,95% CI 1.18-2.38, p = 0.004) 2
• At 48 hours, DKA resolution occurred in 96% (Plasmalyte) vs. 86% (saline) 1

Insulin Infusion Duration:

• Balanced crystalloids reduced median insulin infusion time: 9.8 hours vs. 13.4 hours with saline (adjusted HR 1.45,95% CI 1.03-2.03, p = 0.03) 2

Safety Profile:

• No increase in ketosis with Plasmalyte despite acetate content 1
• Similar rates of acute kidney injury between groups 1, 3
• Comparable mortality and need for renal replacement therapy 3

Practical Implementation Protocol

Initial Fluid Resuscitation

Adults:

• Start with isotonic crystalloid (Plasmalyte-148 or Lactated Ringer's) at 15-20 mL/kg/hour during the first hour 4
• After initial resuscitation, continue at 4-14 mL/kg/hour based on corrected serum sodium 4
• Add potassium supplementation (20-40 mEq/L as 2/3 KCl and 1/3 KPO4) once renal function confirmed and K+ <5.3 mEq/L 4

Pediatric Patients:

• Initial bolus: 10-20 mL/kg/hour of isotonic saline (0.9% NaCl) in first hour, not exceeding 50 mL/kg over first 4 hours 5
• Maintenance: 1.5 times 24-hour maintenance requirements (approximately 5 mL/kg/hour) 5
• Include 20-40 mEq/L potassium (1/3 KPO4 and 2/3 KCl or K-acetate) once renal function assured 5

Insulin Management (Concurrent with Fluids)

Standard Protocol:

• Continuous IV insulin infusion: 0.1 unit/kg/hour (5-7 units/hour in adults) 4, 5
• Target glucose decline: 50-75 mg/dL per hour 4, 5
• When glucose reaches 250 mg/dL, reduce insulin to 0.05-0.1 unit/kg/hour and add dextrose (5-10%) to IV fluids 4

Pediatric Considerations:

• Lower dose insulin (0.05 unit/kg/hour) is equally effective as standard dose (0.1 unit/kg/hour) with fewer hypoglycemia events (3.3% vs. 13.3%) 6

Important Caveats

Monitoring Requirements

• Check electrolytes, glucose, BUN, creatinine, and venous pH every 2-4 hours 5
• Venous pH (typically 0.03 units lower than arterial) and anion gap are sufficient for monitoring; repeat arterial blood gases generally unnecessary 5
• Monitor potassium closely as both insulin and bicarbonate therapy lower serum potassium 5

Cerebral Edema Risk (Pediatrics)

The guidelines emphasize gradual correction to avoid cerebral edema 5:

• Osmolality change should not exceed 3 mOsm/kg/hour
• Avoid excessive fluid administration rates
• Use judicious isotonic fluid approach in children

Potassium Management

• Do not start insulin if K+ <3.3 mEq/L - correct hypokalemia first 5
• Maintain potassium supplementation throughout treatment as insulin drives potassium intracellularly
• Severe hypokalemia (<2.5 mEq/L) during treatment is associated with increased mortality 7

Bicarbonate Therapy

• Not recommended if pH >7.0 5
• May consider if pH <6.9: give 50 mmol sodium bicarbonate in 200 mL sterile water at 200 mL/hour 5
• Studies show no benefit in resolution time or outcomes 8

Resolution Criteria

DKA is resolved when ALL of the following are met 5:

• Glucose <200 mg/dL
• Serum bicarbonate ≥18 mEq/L
• Venous pH >7.3

Transition to Subcutaneous Insulin

Once DKA resolved and patient able to eat 5:

• Continue IV insulin for 1-2 hours after starting subcutaneous regimen to ensure adequate overlap
• Use basal-bolus regimen (combination of rapid/short-acting and intermediate/long-acting insulin)
• Abrupt discontinuation of IV insulin without overlap leads to rebound hyperglycemia and potential recurrent DKA

The evidence strongly supports Plasmalyte or other balanced crystalloids as superior to normal saline for DKA management, with faster metabolic recovery and no safety concerns 1, 2, 9.